Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Journal of Neuro-Oncology
|
June 3, 2025
Super-resolution sodium MRI of human gliomas at 3T using physics-based generative artificial intelligence
Catalina Raymond, Jingwen Yao, Alfredo L Lopez Kolkovsky, et al.
Journal of Neuro-Oncology
|
April 14, 2025
Advanced imaging characterization of post-chemoradiation glioblastoma stratified by diffusion MRI phenotypes known to predict favorable anti-VEGF response
Francesco Sanvito, Irina Kryukov, Jingwen Yao, et al.
Neuro-Oncology
|
December 5, 2021
Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors
Akifumi Hagiwara, Talia C Oughourlian, Nicholas S Cho, et al.
Neuro-Oncology Advances
|
August 11, 2021
Validation of diffusion MRI as a biomarker for efficacy using randomized phase III trial of bevacizumab with or without VB-111 in recurrent glioblastoma
Benjamin M Ellingson, Kunal Patel, Chencai Wang, et al.
CNS Oncology
|
November 13, 2024
Radio-pathomic estimates of cellular growth kinetics predict survival in recurrent glioblastoma
Sonoko Oshima, Jingwen Yao, Samuel Bobholz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2023
Depth of Radiographic Response and Time to Tumor Regrowth Predicts Overall Survival Following Anti-VEGF Therapy in Recurrent Glioblastoma
Benjamin M Ellingson, Akifumi Hagiwara, Connor J Morris, et al.
AJNR. American Journal of Neuroradiology
|
May 30, 2026
Tumor Growth Rate (TGR) Analysis Predicts Survival in a Multicenter Phase II Study of the PARP Inhibitor Pamiparib (BGB-290) with Temozolomide in Recurrent IDH-Mutant Gliomas (ABTC-1801)
Benjamin M Ellingson, Timothy F Cloughesy, Xiaobu Ye, et al.
NMR in Biomedicine
|
June 15, 2022
Amine-weighted chemical exchange saturation transfer magnetic resonance imaging in brain tumors
Nicholas S Cho, Akifumi Hagiwara, Jingwen Yao, et al.
Neuroimage. Clinical
|
December 16, 2021
"Aerobic glycolytic imaging" of human gliomas using combined pH-, oxygen-, and perfusion-weighted magnetic resonance imaging
Akifumi Hagiwara, Jingwen Yao, Catalina Raymond, et al.
Journal of Neuro-Oncology
|
June 9, 2023
Multi-nuclear sodium, diffusion, and perfusion MRI in human gliomas
Nicholas S Cho, Francesco Sanvito, Shruti Thakuria, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Journal of Neuro-Oncology
|
June 3, 2025
Super-resolution sodium MRI of human gliomas at 3T using physics-based generative artificial intelligence
Catalina Raymond, Jingwen Yao, Alfredo L Lopez Kolkovsky, et al.
Journal of Neuro-Oncology
|
April 14, 2025
Advanced imaging characterization of post-chemoradiation glioblastoma stratified by diffusion MRI phenotypes known to predict favorable anti-VEGF response
Francesco Sanvito, Irina Kryukov, Jingwen Yao, et al.
Neuro-Oncology
|
December 5, 2021
Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors
Akifumi Hagiwara, Talia C Oughourlian, Nicholas S Cho, et al.
Neuro-Oncology Advances
|
August 11, 2021
Validation of diffusion MRI as a biomarker for efficacy using randomized phase III trial of bevacizumab with or without VB-111 in recurrent glioblastoma
Benjamin M Ellingson, Kunal Patel, Chencai Wang, et al.
CNS Oncology
|
November 13, 2024
Radio-pathomic estimates of cellular growth kinetics predict survival in recurrent glioblastoma
Sonoko Oshima, Jingwen Yao, Samuel Bobholz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2023
Depth of Radiographic Response and Time to Tumor Regrowth Predicts Overall Survival Following Anti-VEGF Therapy in Recurrent Glioblastoma
Benjamin M Ellingson, Akifumi Hagiwara, Connor J Morris, et al.
AJNR. American Journal of Neuroradiology
|
May 30, 2026
Tumor Growth Rate (TGR) Analysis Predicts Survival in a Multicenter Phase II Study of the PARP Inhibitor Pamiparib (BGB-290) with Temozolomide in Recurrent IDH-Mutant Gliomas (ABTC-1801)
Benjamin M Ellingson, Timothy F Cloughesy, Xiaobu Ye, et al.
NMR in Biomedicine
|
June 15, 2022
Amine-weighted chemical exchange saturation transfer magnetic resonance imaging in brain tumors
Nicholas S Cho, Akifumi Hagiwara, Jingwen Yao, et al.
Neuroimage. Clinical
|
December 16, 2021
"Aerobic glycolytic imaging" of human gliomas using combined pH-, oxygen-, and perfusion-weighted magnetic resonance imaging
Akifumi Hagiwara, Jingwen Yao, Catalina Raymond, et al.
Journal of Neuro-Oncology
|
June 9, 2023
Multi-nuclear sodium, diffusion, and perfusion MRI in human gliomas
Nicholas S Cho, Francesco Sanvito, Shruti Thakuria, et al.
Page
of 7